Related Experiment Video
Updated: Jun 4, 2025
08:00
Dissection and Isolation of Murine Glia from Multiple Central Nervous System Regions
Published on: June 4, 2020
3.2K
Multiple Sclerosis: Glial Cell Diversity in Time and Space
Susanne M Kooistra1, Lucas Schirmer2,3,4,5
1Department of Biomedical Sciences, Section Molecular Neurobiology, University of Groningen and University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Glia
|December 25, 2024
Summary
Glial cells drive multiple sclerosis (MS) lesion progression. Understanding diverse glial subtypes and their dynamic changes is key to developing new MS therapies targeting specific cell types.
Area of Science:
- Neuroimmunology
- Central Nervous System Pathology
Background:
- Multiple sclerosis (MS) is a prevalent inflammatory disease of the central nervous system.
- Demyelination and glial scar formation are hallmarks of MS pathology.
- Glial cells, including microglia, oligodendrocytes, and astrocytes, are central to MS lesion progression, influencing both damage and repair.
Purpose of the Study:
- To review recent developments in glial cell diversity in MS.
- To summarize key findings on the pathological and maladaptive functions of disease-associated glial subtypes.
- To highlight the spatial and temporal dynamics of glial cells during MS lesion progression.
Main Methods:
- Review of recent high-dimensional findings.
- Analysis of epigenomic, transcriptomic, and metabolic features of glial cells.
- Focus on spatial and temporal dynamics of glial subtypes in MS lesions.
Main Results:
- Glial cells exhibit significant diversity and dynamic changes in MS.
- Specific glial subtypes play critical roles in lesion progression, contributing to both damage and repair.
- Epigenomic, transcriptomic, and metabolic alterations are observed in glial cells across MS lesions.
Conclusions:
- Detailed understanding of spatially restricted glial subtype functions is crucial for MS research.
- Knowledge of glial cell dynamics is essential for understanding MS pathogenesis.
- Targeting specific glial cell types holds promise for developing novel MS therapies.
